FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3010264898> ?p ?o ?g. }

• W3010264898 endingPage "3032" @default.
• W3010264898 startingPage "3023" @default.
• W3010264898 abstract "Background The goal of surveillance testing is to enable curative salvage therapy through early disease detection, however supporting evidence in gastroesophageal adenocarcinoma is limited. We evaluated frequency of successful salvage therapy and outcomes in patients who underwent surveillance. Methods A single-site, retrospective cohort study was conducted to identify all patients who received curative resection for gastroesophageal adenocarcinoma. Surveillance testing were those investigations not triggered by abnormal symptoms, physical examination, or blood tests. Successful salvage therapy was any potentially curative therapy for disease recurrence which resulted in postrecurrence disease-free survival ≥2 years. Time-to-event data were analyzed using the Kaplan-Meier method and log rank tests. Results Between 2011 and 2016, 210 consecutive patients were reviewed. Esophageal (14%), gastroesophageal junction (40%), and gastric adenocarcinomas (45%) were treated with surgery alone (29%) or multimodality therapy (71%). Adjuvant therapy was administered in 35%. At median follow-up of 38.3 months, 5-year overall survival (OS) rate was 56%. Among 97 recurrences, 53% were surveillance-detected, and 46% were symptomatic. None was detected by surveillance endoscopy. Median time-to-recurrence (TTR) was 14.8 months. Recurrences included locoregional only (4%), distant (86%), and both (10%). Salvage therapy was attempted in 15 patients, 4 were successful. Compared to symptomatic recurrences, patients with surveillance-detected recurrences had longer median OS (36.2 vs 23.7 months, P = .004) and postrecurrence survival (PRS, 16.5 vs 4.6 months, P < .001), but similar TTR (16.2 vs 13.3 months, P = .40) and duration of palliative chemotherapy (3.9 vs 3.3 months, P = .64). Conclusions Among patients surveyed, 96% of recurrences were distant, and salvage therapy was successful in only 1.9% of patients. Longer OS in patients with surveillance-detected compared to symptomatic recurrences was not associated with significant earlier disease detection, and may be contributed by differences in disease biology. Further prospective data are warranted to establish the benefit of surveillance testing in gastroesophageal adenocarcinoma." @default.
• W3010264898 created "2020-03-13" @default.
• W3010264898 creator A5002216968 @default.
• W3010264898 creator A5007898155 @default.
• W3010264898 creator A5013483415 @default.
• W3010264898 creator A5016712043 @default.
• W3010264898 creator A5018826864 @default.
• W3010264898 creator A5023531951 @default.
• W3010264898 creator A5030996675 @default.
• W3010264898 creator A5038910607 @default.
• W3010264898 creator A5043693232 @default.
• W3010264898 creator A5053712285 @default.
• W3010264898 creator A5056959902 @default.
• W3010264898 creator A5058708824 @default.
• W3010264898 creator A5065784545 @default.
• W3010264898 creator A5067593529 @default.
• W3010264898 creator A5067772666 @default.
• W3010264898 creator A5072717802 @default.
• W3010264898 creator A5080981788 @default.
• W3010264898 date "2020-03-04" @default.
• W3010264898 modified "2023-10-12" @default.
• W3010264898 title "Surveillance and outcomes after curative resection for gastroesophageal adenocarcinoma" @default.
• W3010264898 cites W1991097958 @default.
• W3010264898 cites W1996923403 @default.
• W3010264898 cites W2002832192 @default.
• W3010264898 cites W2009812249 @default.
• W3010264898 cites W2010129875 @default.
• W3010264898 cites W2012548822 @default.
• W3010264898 cites W2026986976 @default.
• W3010264898 cites W2030713636 @default.
• W3010264898 cites W2033970098 @default.
• W3010264898 cites W2040343520 @default.
• W3010264898 cites W2064777734 @default.
• W3010264898 cites W2093107403 @default.
• W3010264898 cites W2099998407 @default.
• W3010264898 cites W2104951678 @default.
• W3010264898 cites W2115072149 @default.
• W3010264898 cites W2129787938 @default.
• W3010264898 cites W2137696504 @default.
• W3010264898 cites W2153930560 @default.
• W3010264898 cites W2154444715 @default.
• W3010264898 cites W2283921423 @default.
• W3010264898 cites W2395889494 @default.
• W3010264898 cites W2570401594 @default.
• W3010264898 cites W2735001381 @default.
• W3010264898 cites W776082871 @default.
• W3010264898 doi "https://doi.org/10.1002/cam4.2948" @default.
• W3010264898 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7196047" @default.
• W3010264898 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32130793" @default.
• W3010264898 hasPublicationYear "2020" @default.
• W3010264898 type Work @default.
• W3010264898 sameAs 3010264898 @default.
• W3010264898 citedByCount "5" @default.
• W3010264898 countsByYear W30102648982020 @default.
• W3010264898 countsByYear W30102648982021 @default.
• W3010264898 countsByYear W30102648982022 @default.
• W3010264898 crossrefType "journal-article" @default.
• W3010264898 hasAuthorship W3010264898A5002216968 @default.
• W3010264898 hasAuthorship W3010264898A5007898155 @default.
• W3010264898 hasAuthorship W3010264898A5013483415 @default.
• W3010264898 hasAuthorship W3010264898A5016712043 @default.
• W3010264898 hasAuthorship W3010264898A5018826864 @default.
• W3010264898 hasAuthorship W3010264898A5023531951 @default.
• W3010264898 hasAuthorship W3010264898A5030996675 @default.
• W3010264898 hasAuthorship W3010264898A5038910607 @default.
• W3010264898 hasAuthorship W3010264898A5043693232 @default.
• W3010264898 hasAuthorship W3010264898A5053712285 @default.
• W3010264898 hasAuthorship W3010264898A5056959902 @default.
• W3010264898 hasAuthorship W3010264898A5058708824 @default.
• W3010264898 hasAuthorship W3010264898A5065784545 @default.
• W3010264898 hasAuthorship W3010264898A5067593529 @default.
• W3010264898 hasAuthorship W3010264898A5067772666 @default.
• W3010264898 hasAuthorship W3010264898A5072717802 @default.
• W3010264898 hasAuthorship W3010264898A5080981788 @default.
• W3010264898 hasBestOaLocation W30102648981 @default.
• W3010264898 hasConcept C10515644 @default.
• W3010264898 hasConcept C121608353 @default.
• W3010264898 hasConcept C126322002 @default.
• W3010264898 hasConcept C141071460 @default.
• W3010264898 hasConcept C167135981 @default.
• W3010264898 hasConcept C195910791 @default.
• W3010264898 hasConcept C2776694085 @default.
• W3010264898 hasConcept C2777982462 @default.
• W3010264898 hasConcept C2780775027 @default.
• W3010264898 hasConcept C2781182431 @default.
• W3010264898 hasConcept C66339696 @default.
• W3010264898 hasConcept C71924100 @default.
• W3010264898 hasConcept C72563966 @default.
• W3010264898 hasConceptScore W3010264898C10515644 @default.
• W3010264898 hasConceptScore W3010264898C121608353 @default.
• W3010264898 hasConceptScore W3010264898C126322002 @default.
• W3010264898 hasConceptScore W3010264898C141071460 @default.
• W3010264898 hasConceptScore W3010264898C167135981 @default.
• W3010264898 hasConceptScore W3010264898C195910791 @default.
• W3010264898 hasConceptScore W3010264898C2776694085 @default.
• W3010264898 hasConceptScore W3010264898C2777982462 @default.
• W3010264898 hasConceptScore W3010264898C2780775027 @default.
• W3010264898 hasConceptScore W3010264898C2781182431 @default.

• next